| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 117 | 2024 | 785 | 17.000 |
Why?
|
| Vibrio cholerae O1 | 51 | 2024 | 242 | 10.300 |
Why?
|
| Cholera Vaccines | 49 | 2024 | 268 | 10.040 |
Why?
|
| Antibodies, Bacterial | 83 | 2024 | 1470 | 9.180 |
Why?
|
| O Antigens | 25 | 2024 | 193 | 7.370 |
Why?
|
| Typhoid Fever | 30 | 2023 | 197 | 6.540 |
Why?
|
| Vibrio cholerae | 56 | 2023 | 806 | 5.710 |
Why?
|
| Salmonella typhi | 25 | 2023 | 201 | 5.490 |
Why?
|
| Travel | 40 | 2024 | 788 | 4.380 |
Why?
|
| Bangladesh | 79 | 2023 | 687 | 3.770 |
Why?
|
| Immunoglobulin A | 51 | 2024 | 992 | 3.590 |
Why?
|
| Vibrio cholerae O139 | 14 | 2023 | 54 | 3.120 |
Why?
|
| Diarrhea | 30 | 2023 | 1348 | 2.900 |
Why?
|
| Vaccines, Conjugate | 13 | 2023 | 333 | 2.840 |
Why?
|
| Immunologic Memory | 27 | 2022 | 1348 | 2.710 |
Why?
|
| Antigens, Bacterial | 24 | 2022 | 1171 | 2.650 |
Why?
|
| Vaccination | 38 | 2024 | 3278 | 2.400 |
Why?
|
| Immunoglobulin M | 26 | 2024 | 1537 | 2.340 |
Why?
|
| Immunoglobulin G | 61 | 2024 | 4560 | 2.060 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 490 | 1.920 |
Why?
|
| Cholera Toxin | 33 | 2024 | 556 | 1.850 |
Why?
|
| Salmonella paratyphi A | 8 | 2017 | 47 | 1.770 |
Why?
|
| Travel Medicine | 9 | 2023 | 84 | 1.710 |
Why?
|
| Paratyphoid Fever | 6 | 2016 | 35 | 1.610 |
Why?
|
| Dysentery, Bacillary | 5 | 2023 | 75 | 1.580 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 3 | 2020 | 39 | 1.550 |
Why?
|
| Bacteremia | 12 | 2015 | 962 | 1.520 |
Why?
|
| B-Lymphocytes | 26 | 2022 | 4665 | 1.440 |
Why?
|
| Shigella | 5 | 2023 | 74 | 1.370 |
Why?
|
| Immunity, Humoral | 5 | 2020 | 598 | 1.370 |
Why?
|
| Lipopolysaccharides | 21 | 2023 | 2216 | 1.200 |
Why?
|
| Communicable Disease Control | 9 | 2018 | 857 | 1.170 |
Why?
|
| Antibody-Producing Cells | 10 | 2021 | 143 | 1.120 |
Why?
|
| Shigella Vaccines | 2 | 2023 | 7 | 1.030 |
Why?
|
| Parasitic Diseases | 4 | 2021 | 75 | 1.020 |
Why?
|
| Blood Group Antigens | 4 | 2023 | 180 | 1.020 |
Why?
|
| Disease Outbreaks | 15 | 2020 | 1772 | 1.000 |
Why?
|
| Antibody Formation | 12 | 2024 | 1402 | 1.000 |
Why?
|
| Salmonella Infections | 3 | 2015 | 173 | 0.980 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 69 | 0.970 |
Why?
|
| Diarrhea, Infantile | 2 | 2015 | 109 | 0.960 |
Why?
|
| Child, Preschool | 74 | 2024 | 41006 | 0.950 |
Why?
|
| Escherichia coli Infections | 7 | 2018 | 532 | 0.940 |
Why?
|
| Communicable Diseases | 10 | 2018 | 880 | 0.920 |
Why?
|
| Serologic Tests | 5 | 2020 | 374 | 0.920 |
Why?
|
| Feces | 19 | 2022 | 1401 | 0.910 |
Why?
|
| Carrier State | 4 | 2021 | 518 | 0.900 |
Why?
|
| Antibodies, Viral | 16 | 2023 | 3176 | 0.890 |
Why?
|
| Tetanus Toxin | 3 | 2023 | 49 | 0.800 |
Why?
|
| Bacterial Proteins | 13 | 2022 | 3848 | 0.790 |
Why?
|
| Child | 86 | 2024 | 77709 | 0.770 |
Why?
|
| Mucous Membrane | 5 | 2019 | 673 | 0.760 |
Why?
|
| Administration, Oral | 22 | 2021 | 3913 | 0.760 |
Why?
|
| Virus Diseases | 4 | 2021 | 711 | 0.760 |
Why?
|
| Vaccines, Inactivated | 13 | 2023 | 184 | 0.750 |
Why?
|
| Salmonella | 4 | 2022 | 129 | 0.730 |
Why?
|
| Fever | 5 | 2024 | 1616 | 0.730 |
Why?
|
| Bacterial Vaccines | 6 | 2009 | 403 | 0.710 |
Why?
|
| Host-Pathogen Interactions | 6 | 2021 | 1477 | 0.710 |
Why?
|
| Enterotoxigenic Escherichia coli | 6 | 2018 | 32 | 0.700 |
Why?
|
| Humans | 262 | 2024 | 744343 | 0.690 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2019 | 567 | 0.680 |
Why?
|
| Vitreous Body | 3 | 2010 | 389 | 0.660 |
Why?
|
| Adolescent | 88 | 2024 | 85781 | 0.630 |
Why?
|
| Measles | 4 | 2022 | 168 | 0.620 |
Why?
|
| Enterotoxins | 5 | 2016 | 368 | 0.600 |
Why?
|
| Antifungal Agents | 1 | 2022 | 730 | 0.590 |
Why?
|
| Endophthalmitis | 3 | 2010 | 262 | 0.590 |
Why?
|
| Young Adult | 72 | 2022 | 56430 | 0.590 |
Why?
|
| Dehydration | 4 | 2022 | 234 | 0.560 |
Why?
|
| Adult | 121 | 2024 | 214055 | 0.560 |
Why?
|
| Disease Transmission, Infectious | 3 | 2018 | 547 | 0.560 |
Why?
|
| Vaccines | 6 | 2023 | 822 | 0.550 |
Why?
|
| Headache | 1 | 2024 | 1226 | 0.540 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 4 | 2022 | 66 | 0.540 |
Why?
|
| Rubella | 3 | 2022 | 48 | 0.530 |
Why?
|
| Disasters | 3 | 2006 | 511 | 0.530 |
Why?
|
| Immunization | 9 | 2020 | 1256 | 0.520 |
Why?
|
| Mumps | 3 | 2022 | 64 | 0.520 |
Why?
|
| Anti-Bacterial Agents | 18 | 2023 | 7181 | 0.510 |
Why?
|
| Plasma | 1 | 2018 | 575 | 0.500 |
Why?
|
| Vaccines, Attenuated | 7 | 2022 | 342 | 0.500 |
Why?
|
| Female | 138 | 2023 | 380194 | 0.490 |
Why?
|
| Bacterial Toxins | 6 | 2016 | 931 | 0.470 |
Why?
|
| Campylobacter Infections | 1 | 2013 | 32 | 0.470 |
Why?
|
| Entamoebiasis | 1 | 2013 | 14 | 0.470 |
Why?
|
| Fimbriae Proteins | 8 | 2015 | 134 | 0.460 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2016 | 602 | 0.460 |
Why?
|
| Vaccines, Synthetic | 7 | 2022 | 634 | 0.460 |
Why?
|
| Infant | 41 | 2022 | 35136 | 0.460 |
Why?
|
| Pandemics | 12 | 2021 | 8388 | 0.450 |
Why?
|
| Male | 123 | 2024 | 350118 | 0.450 |
Why?
|
| Eye Diseases | 2 | 2009 | 669 | 0.450 |
Why?
|
| Islam | 1 | 2014 | 69 | 0.450 |
Why?
|
| Yellow Fever | 3 | 2021 | 53 | 0.440 |
Why?
|
| Enterobacteriaceae | 4 | 2023 | 169 | 0.440 |
Why?
|
| Blood | 4 | 2016 | 598 | 0.440 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 390 | 0.440 |
Why?
|
| Gallbladder | 1 | 2014 | 302 | 0.440 |
Why?
|
| Retinal Diseases | 2 | 2009 | 683 | 0.430 |
Why?
|
| Rotavirus Infections | 1 | 2013 | 86 | 0.430 |
Why?
|
| Biliary Tract | 1 | 2013 | 134 | 0.430 |
Why?
|
| Sarcocystidae | 1 | 2011 | 2 | 0.420 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2017 | 1836 | 0.420 |
Why?
|
| Coccidiosis | 1 | 2011 | 13 | 0.420 |
Why?
|
| Public Health Administration | 2 | 2013 | 240 | 0.410 |
Why?
|
| Administration, Cutaneous | 5 | 2020 | 711 | 0.400 |
Why?
|
| Bacterial Infections | 3 | 2017 | 1401 | 0.390 |
Why?
|
| Haiti | 9 | 2019 | 553 | 0.380 |
Why?
|
| Gastroenteritis | 1 | 2013 | 245 | 0.380 |
Why?
|
| Antibodies, Protozoan | 4 | 2012 | 253 | 0.380 |
Why?
|
| Middle Aged | 74 | 2022 | 213383 | 0.370 |
Why?
|
| Glycoconjugates | 2 | 2023 | 87 | 0.370 |
Why?
|
| Mice | 25 | 2023 | 81183 | 0.360 |
Why?
|
| Basketball | 2 | 2021 | 49 | 0.360 |
Why?
|
| Family Characteristics | 8 | 2018 | 1000 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9274 | 0.360 |
Why?
|
| Malaria | 7 | 2017 | 1239 | 0.350 |
Why?
|
| Cryptosporidiosis | 4 | 2012 | 60 | 0.350 |
Why?
|
| Animals | 43 | 2023 | 168757 | 0.350 |
Why?
|
| Lymphocytes | 4 | 2022 | 2617 | 0.350 |
Why?
|
| Immunoassay | 3 | 2020 | 752 | 0.340 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 351 | 0.330 |
Why?
|
| Convalescence | 3 | 2021 | 105 | 0.330 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2020 | 1035 | 0.330 |
Why?
|
| Immunization Programs | 2 | 2018 | 260 | 0.330 |
Why?
|
| Antimalarials | 5 | 2016 | 905 | 0.320 |
Why?
|
| Internationality | 4 | 2024 | 1003 | 0.320 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 972 | 0.310 |
Why?
|
| Blood Bactericidal Activity | 6 | 2015 | 126 | 0.300 |
Why?
|
| Antibodies, Neutralizing | 6 | 2022 | 1978 | 0.300 |
Why?
|
| Bacillus anthracis | 1 | 2008 | 123 | 0.300 |
Why?
|
| Fasting | 1 | 2014 | 1593 | 0.300 |
Why?
|
| Asia | 3 | 2018 | 610 | 0.300 |
Why?
|
| Yellow Fever Vaccine | 2 | 2021 | 37 | 0.300 |
Why?
|
| Vitrectomy | 1 | 2010 | 365 | 0.300 |
Why?
|
| Leptin | 1 | 2015 | 1599 | 0.290 |
Why?
|
| Schistosomiasis mansoni | 1 | 2007 | 85 | 0.290 |
Why?
|
| Fungemia | 1 | 2007 | 53 | 0.290 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2015 | 1122 | 0.280 |
Why?
|
| Disease Models, Animal | 10 | 2023 | 18029 | 0.280 |
Why?
|
| Cryptosporidium | 4 | 2012 | 45 | 0.280 |
Why?
|
| Interferon-gamma | 2 | 2014 | 3206 | 0.280 |
Why?
|
| Shigella dysenteriae | 1 | 2005 | 14 | 0.280 |
Why?
|
| Eye Infections, Bacterial | 2 | 2007 | 235 | 0.280 |
Why?
|
| Neuraminidase | 3 | 2022 | 210 | 0.280 |
Why?
|
| Proteomics | 6 | 2022 | 3638 | 0.280 |
Why?
|
| Escherichia coli | 7 | 2023 | 4217 | 0.270 |
Why?
|
| Proteome | 2 | 2013 | 1799 | 0.270 |
Why?
|
| Onchocerciasis | 1 | 2005 | 24 | 0.270 |
Why?
|
| Duodenum | 5 | 2022 | 483 | 0.270 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 9438 | 0.270 |
Why?
|
| Salmonella enterica | 2 | 2016 | 75 | 0.270 |
Why?
|
| Intestinal Diseases | 3 | 2016 | 530 | 0.270 |
Why?
|
| Immunization Schedule | 3 | 2023 | 221 | 0.270 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 3133 | 0.260 |
Why?
|
| Eye Infections, Fungal | 1 | 2007 | 110 | 0.260 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 3240 | 0.260 |
Why?
|
| Lung Abscess | 1 | 2005 | 42 | 0.260 |
Why?
|
| Suture Techniques | 1 | 2010 | 798 | 0.260 |
Why?
|
| T-Lymphocytes | 6 | 2021 | 10180 | 0.260 |
Why?
|
| Escherichia coli Proteins | 5 | 2016 | 1050 | 0.260 |
Why?
|
| Weather | 1 | 2006 | 228 | 0.260 |
Why?
|
| Shigella flexneri | 2 | 2023 | 132 | 0.260 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2005 | 110 | 0.260 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2003 | 103 | 0.260 |
Why?
|
| Magnetite Nanoparticles | 2 | 2017 | 321 | 0.260 |
Why?
|
| Chromatography, Affinity | 3 | 2020 | 549 | 0.250 |
Why?
|
| Insect Bites and Stings | 2 | 2018 | 67 | 0.250 |
Why?
|
| Microsurgery | 1 | 2010 | 796 | 0.250 |
Why?
|
| Bacteriological Techniques | 2 | 2018 | 277 | 0.250 |
Why?
|
| Treatment Refusal | 3 | 2017 | 421 | 0.250 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 218 | 0.250 |
Why?
|
| Pakistan | 3 | 2023 | 295 | 0.250 |
Why?
|
| Brain Abscess | 1 | 2005 | 118 | 0.240 |
Why?
|
| Intestines | 7 | 2016 | 1924 | 0.240 |
Why?
|
| Specimen Handling | 2 | 2020 | 694 | 0.240 |
Why?
|
| Pneumonia, Aspiration | 1 | 2005 | 145 | 0.240 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2023 | 187 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2024 | 3923 | 0.240 |
Why?
|
| Rabbits | 6 | 2023 | 4894 | 0.240 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 382 | 0.240 |
Why?
|
| Antibody Affinity | 3 | 2014 | 254 | 0.240 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 386 | 0.240 |
Why?
|
| Paresis | 1 | 2005 | 179 | 0.240 |
Why?
|
| Colistin | 2 | 2023 | 47 | 0.230 |
Why?
|
| Occupational Health | 2 | 2016 | 809 | 0.230 |
Why?
|
| Hafnia | 1 | 2023 | 3 | 0.230 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 1782 | 0.230 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 2003 | 7 | 0.230 |
Why?
|
| Pneumonia | 1 | 2015 | 2133 | 0.230 |
Why?
|
| Yersinia pestis | 1 | 2003 | 33 | 0.230 |
Why?
|
| Plague | 1 | 2003 | 22 | 0.230 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5524 | 0.230 |
Why?
|
| Syphilis | 1 | 2005 | 227 | 0.220 |
Why?
|
| Antitoxins | 3 | 2019 | 81 | 0.220 |
Why?
|
| Carbapenems | 2 | 2023 | 118 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2013 | 3022 | 0.220 |
Why?
|
| Antibody Specificity | 4 | 2021 | 1095 | 0.220 |
Why?
|
| Bioterrorism | 1 | 2003 | 143 | 0.210 |
Why?
|
| Enzyme-Linked Immunospot Assay | 3 | 2017 | 130 | 0.210 |
Why?
|
| Antigens, Protozoan | 3 | 2012 | 322 | 0.210 |
Why?
|
| Genetic Vectors | 4 | 2000 | 3420 | 0.210 |
Why?
|
| Seasons | 3 | 2023 | 1493 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 3 | 2020 | 1000 | 0.200 |
Why?
|
| History, 21st Century | 3 | 2018 | 1534 | 0.200 |
Why?
|
| Developing Countries | 9 | 2014 | 2815 | 0.200 |
Why?
|
| Protein Array Analysis | 2 | 2013 | 411 | 0.200 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2018 | 1838 | 0.200 |
Why?
|
| Entamoeba histolytica | 2 | 2000 | 30 | 0.200 |
Why?
|
| Adhesins, Bacterial | 2 | 1999 | 119 | 0.200 |
Why?
|
| Sensitivity and Specificity | 13 | 2020 | 14722 | 0.200 |
Why?
|
| Anthozoa | 1 | 2021 | 62 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2018 | 4558 | 0.200 |
Why?
|
| Cross Reactions | 5 | 2022 | 841 | 0.200 |
Why?
|
| Agglutination | 1 | 2020 | 43 | 0.200 |
Why?
|
| Eosinophilia | 1 | 2005 | 541 | 0.200 |
Why?
|
| Animals, Suckling | 1 | 2020 | 72 | 0.190 |
Why?
|
| Immunity, Innate | 4 | 2019 | 2958 | 0.190 |
Why?
|
| Immunization, Secondary | 2 | 2021 | 340 | 0.190 |
Why?
|
| Genome, Bacterial | 4 | 2018 | 760 | 0.190 |
Why?
|
| Neurocysticercosis | 1 | 2021 | 62 | 0.190 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.190 |
Why?
|
| Phylogeny | 5 | 2021 | 2803 | 0.190 |
Why?
|
| Altitude Sickness | 2 | 2018 | 92 | 0.190 |
Why?
|
| United States | 27 | 2023 | 69872 | 0.190 |
Why?
|
| RNA, Messenger | 7 | 2023 | 13033 | 0.190 |
Why?
|
| Hemolysin Proteins | 2 | 2017 | 113 | 0.190 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 77 | 0.180 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12959 | 0.180 |
Why?
|
| Shiga Toxins | 2 | 1999 | 41 | 0.180 |
Why?
|
| Peroxidase | 2 | 2021 | 611 | 0.180 |
Why?
|
| Contact Tracing | 2 | 2014 | 273 | 0.180 |
Why?
|
| Athletic Injuries | 2 | 2021 | 1154 | 0.180 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2000 | 74 | 0.180 |
Why?
|
| Chemoprevention | 3 | 2023 | 319 | 0.180 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.180 |
Why?
|
| Plasmids | 3 | 2017 | 2307 | 0.180 |
Why?
|
| Metagenomics | 2 | 2021 | 428 | 0.180 |
Why?
|
| Laboratories, Hospital | 1 | 2021 | 194 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2023 | 1877 | 0.170 |
Why?
|
| Serotyping | 4 | 2015 | 338 | 0.170 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 819 | 0.170 |
Why?
|
| Hospitals | 7 | 2020 | 3952 | 0.170 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 2019 | 17 | 0.170 |
Why?
|
| Nepal | 3 | 2018 | 295 | 0.170 |
Why?
|
| Microbial Viability | 4 | 2020 | 234 | 0.170 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 3036 | 0.170 |
Why?
|
| Antigens | 1 | 2005 | 1466 | 0.170 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2020 | 578 | 0.170 |
Why?
|
| Health Behavior | 1 | 2010 | 2636 | 0.160 |
Why?
|
| Antibiosis | 1 | 2018 | 45 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2022 | 360 | 0.160 |
Why?
|
| Preventive Medicine | 1 | 2000 | 264 | 0.160 |
Why?
|
| Lung | 3 | 2007 | 9856 | 0.160 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 468 | 0.160 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 933 | 0.160 |
Why?
|
| History, 20th Century | 2 | 2018 | 2740 | 0.160 |
Why?
|
| Barotrauma | 1 | 2018 | 37 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 738 | 0.160 |
Why?
|
| Food Safety | 1 | 2018 | 22 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2023 | 503 | 0.160 |
Why?
|
| Desiccation | 1 | 2018 | 70 | 0.160 |
Why?
|
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.160 |
Why?
|
| Protozoan Vaccines | 1 | 1997 | 13 | 0.160 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2021 | 323 | 0.160 |
Why?
|
| Retina | 1 | 2009 | 2616 | 0.150 |
Why?
|
| Athletic Performance | 1 | 2018 | 95 | 0.150 |
Why?
|
| Molecular Typing | 2 | 2015 | 106 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3508 | 0.150 |
Why?
|
| Ships | 1 | 2018 | 61 | 0.150 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2001 | 590 | 0.150 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 316 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2020 | 582 | 0.150 |
Why?
|
| Endemic Diseases | 2 | 2014 | 182 | 0.150 |
Why?
|
| Aircraft | 1 | 2018 | 123 | 0.150 |
Why?
|
| Mosquito Nets | 1 | 2016 | 5 | 0.150 |
Why?
|
| Cyclobutanes | 1 | 2017 | 59 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2020 | 667 | 0.140 |
Why?
|
| Insect Repellents | 1 | 2016 | 17 | 0.140 |
Why?
|
| Zoonoses | 1 | 2018 | 185 | 0.140 |
Why?
|
| Flagellin | 1 | 2017 | 125 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 2 | 2014 | 256 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 2020 | 1035 | 0.140 |
Why?
|
| beta-Lactamases | 3 | 2023 | 306 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 436 | 0.140 |
Why?
|
| North America | 1 | 2019 | 1249 | 0.140 |
Why?
|
| Protective Clothing | 1 | 2016 | 102 | 0.140 |
Why?
|
| Risk Factors | 17 | 2023 | 72290 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6386 | 0.140 |
Why?
|
| Eye Infections, Parasitic | 1 | 1996 | 24 | 0.140 |
Why?
|
| Medicine | 2 | 2023 | 946 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 738 | 0.140 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 645 | 0.130 |
Why?
|
| Risk Assessment | 12 | 2018 | 23338 | 0.130 |
Why?
|
| Health Services Misuse | 1 | 2017 | 243 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 5 | 2022 | 5391 | 0.130 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 109 | 0.130 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2018 | 624 | 0.130 |
Why?
|
| Infant, Newborn | 13 | 2024 | 25625 | 0.130 |
Why?
|
| Probiotics | 1 | 2019 | 351 | 0.130 |
Why?
|
| Immunologic Tests | 1 | 2016 | 103 | 0.130 |
Why?
|
| Geography | 1 | 2018 | 669 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 121 | 0.130 |
Why?
|
| DNA Probes | 1 | 2016 | 560 | 0.130 |
Why?
|
| Age Factors | 5 | 2021 | 18370 | 0.130 |
Why?
|
| Geographic Information Systems | 1 | 2018 | 281 | 0.130 |
Why?
|
| Severity of Illness Index | 7 | 2022 | 15540 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4751 | 0.130 |
Why?
|
| Aged | 26 | 2024 | 163280 | 0.130 |
Why?
|
| Dominican Republic | 2 | 2012 | 76 | 0.130 |
Why?
|
| Infant Nutrition Disorders | 1 | 2015 | 73 | 0.130 |
Why?
|
| Bacterial Shedding | 1 | 2014 | 10 | 0.130 |
Why?
|
| Japanese Encephalitis Vaccines | 1 | 2014 | 6 | 0.130 |
Why?
|
| Case-Control Studies | 9 | 2019 | 21746 | 0.130 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2014 | 11 | 0.130 |
Why?
|
| Albendazole | 1 | 2014 | 33 | 0.130 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2014 | 24 | 0.130 |
Why?
|
| Encephalitis, Japanese | 1 | 2014 | 12 | 0.130 |
Why?
|
| Anterior Eye Segment | 1 | 1996 | 152 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 82 | 0.120 |
Why?
|
| Acute Disease | 6 | 2018 | 7149 | 0.120 |
Why?
|
| Epidemics | 2 | 2018 | 523 | 0.120 |
Why?
|
| Dengue | 1 | 2017 | 256 | 0.120 |
Why?
|
| Cohort Studies | 16 | 2022 | 40561 | 0.120 |
Why?
|
| Exanthema | 1 | 2019 | 501 | 0.120 |
Why?
|
| Rabies Vaccines | 1 | 2013 | 31 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2020 | 3870 | 0.120 |
Why?
|
| Leisure Activities | 1 | 2016 | 311 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2020 | 3772 | 0.120 |
Why?
|
| Hospitalization | 5 | 2021 | 10262 | 0.120 |
Why?
|
| History, 16th Century | 1 | 2013 | 72 | 0.120 |
Why?
|
| Haplotypes | 2 | 2018 | 2779 | 0.120 |
Why?
|
| Serum Albumin, Bovine | 2 | 2017 | 324 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2002 | 1065 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2013 | 111 | 0.120 |
Why?
|
| Rabies | 1 | 2013 | 61 | 0.110 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 827 | 0.110 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 814 | 0.110 |
Why?
|
| Lectins | 1 | 2016 | 513 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2004 | 1796 | 0.110 |
Why?
|
| Peptides | 2 | 2020 | 4409 | 0.110 |
Why?
|
| Prophages | 1 | 2013 | 38 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 6622 | 0.110 |
Why?
|
| AIDS Vaccines | 1 | 2020 | 938 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 986 | 0.110 |
Why?
|
| History, 18th Century | 1 | 2013 | 214 | 0.110 |
Why?
|
| Rural Population | 3 | 2018 | 2210 | 0.110 |
Why?
|
| Nucleic Acids | 1 | 2015 | 182 | 0.110 |
Why?
|
| Child Nutrition Disorders | 1 | 2014 | 149 | 0.110 |
Why?
|
| HIV Infections | 3 | 2017 | 16718 | 0.110 |
Why?
|
| Biosensing Techniques | 2 | 2017 | 668 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 634 | 0.110 |
Why?
|
| Time Factors | 12 | 2020 | 40075 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2017 | 568 | 0.110 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2014 | 172 | 0.110 |
Why?
|
| Family Health | 3 | 2018 | 1282 | 0.110 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2309 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1170 | 0.110 |
Why?
|
| Environmental Illness | 1 | 2012 | 34 | 0.110 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 486 | 0.110 |
Why?
|
| Cholecystectomy | 1 | 2014 | 395 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2023 | 1479 | 0.100 |
Why?
|
| Protozoan Infections | 1 | 2011 | 39 | 0.100 |
Why?
|
| Viral Load | 4 | 2022 | 3299 | 0.100 |
Why?
|
| Urban Population | 3 | 2015 | 2021 | 0.100 |
Why?
|
| Health Planning Guidelines | 1 | 2012 | 163 | 0.100 |
Why?
|
| Virulence | 3 | 2015 | 1333 | 0.100 |
Why?
|
| Ileus | 1 | 2011 | 58 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2020 | 758 | 0.100 |
Why?
|
| Immunocompromised Host | 2 | 2015 | 847 | 0.100 |
Why?
|
| Incidence | 8 | 2022 | 20947 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1177 | 0.100 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 57776 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2017 | 810 | 0.100 |
Why?
|
| Malnutrition | 2 | 2014 | 625 | 0.100 |
Why?
|
| Cholecystitis | 1 | 1992 | 182 | 0.100 |
Why?
|
| Sanitation | 1 | 2011 | 93 | 0.100 |
Why?
|
| Rivers | 2 | 2013 | 66 | 0.100 |
Why?
|
| Genetic Variation | 3 | 2017 | 6544 | 0.100 |
Why?
|
| History, 19th Century | 1 | 2013 | 720 | 0.100 |
Why?
|
| Germ-Free Life | 3 | 2000 | 188 | 0.100 |
Why?
|
| Plasmodium falciparum | 1 | 2001 | 1732 | 0.100 |
Why?
|
| Ciprofloxacin | 1 | 2013 | 315 | 0.100 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 267 | 0.090 |
Why?
|
| Safety | 1 | 2015 | 1186 | 0.090 |
Why?
|
| Hypokalemia | 1 | 2011 | 153 | 0.090 |
Why?
|
| Aviation | 1 | 2010 | 42 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2203 | 0.090 |
Why?
|
| Commerce | 1 | 2016 | 592 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 19905 | 0.090 |
Why?
|
| Paralysis | 1 | 2011 | 247 | 0.090 |
Why?
|
| Hirschsprung Disease | 1 | 1992 | 155 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15295 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.090 |
Why?
|
| Arthritis, Reactive | 1 | 2009 | 19 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2596 | 0.090 |
Why?
|
| Cytokines | 5 | 2019 | 7322 | 0.090 |
Why?
|
| Minisatellite Repeats | 1 | 2010 | 165 | 0.090 |
Why?
|
| Incontinentia Pigmenti | 1 | 2009 | 10 | 0.090 |
Why?
|
| Species Specificity | 2 | 2015 | 2478 | 0.090 |
Why?
|
| Population Density | 1 | 2010 | 196 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2013 | 19229 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7880 | 0.090 |
Why?
|
| Demography | 4 | 2015 | 1656 | 0.090 |
Why?
|
| Breast Feeding | 1 | 2017 | 1338 | 0.090 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 66 | 0.080 |
Why?
|
| Seizures | 1 | 2021 | 2859 | 0.080 |
Why?
|
| Metagenome | 2 | 2023 | 418 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 7785 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 133 | 0.080 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 25043 | 0.080 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 39 | 0.080 |
Why?
|
| Helminthiasis | 1 | 2009 | 66 | 0.080 |
Why?
|
| Macaca mulatta | 2 | 2021 | 2375 | 0.080 |
Why?
|
| Floods | 1 | 2008 | 42 | 0.080 |
Why?
|
| Fluid Therapy | 2 | 2012 | 593 | 0.080 |
Why?
|
| Hygiene | 1 | 2008 | 98 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 1999 | 5021 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2013 | 645 | 0.080 |
Why?
|
| Fimbriae, Bacterial | 2 | 2005 | 138 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2015 | 1167 | 0.080 |
Why?
|
| Counseling | 2 | 2015 | 1523 | 0.080 |
Why?
|
| Pregnancy | 6 | 2023 | 29144 | 0.080 |
Why?
|
| Bartonella | 1 | 2007 | 12 | 0.080 |
Why?
|
| Rotavirus | 1 | 2008 | 109 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2009 | 2038 | 0.080 |
Why?
|
| Toxoids | 1 | 2007 | 12 | 0.080 |
Why?
|
| Bartonella Infections | 1 | 2007 | 22 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 767 | 0.080 |
Why?
|
| World Health Organization | 1 | 2013 | 1318 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1917 | 0.080 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 783 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2635 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3474 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2017 | 2026 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2010 | 2050 | 0.070 |
Why?
|
| Proteins | 2 | 2013 | 6103 | 0.070 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2007 | 83 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12245 | 0.070 |
Why?
|
| Primaquine | 1 | 2006 | 28 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2010 | 494 | 0.070 |
Why?
|
| Length of Stay | 1 | 2000 | 6309 | 0.070 |
Why?
|
| Tropical Medicine | 2 | 2004 | 49 | 0.070 |
Why?
|
| Schistosoma mansoni | 1 | 2007 | 149 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 2872 | 0.070 |
Why?
|
| Lovastatin | 1 | 2006 | 120 | 0.070 |
Why?
|
| Filaricides | 1 | 2005 | 9 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2183 | 0.070 |
Why?
|
| Penicillin G Benzathine | 1 | 2005 | 24 | 0.070 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2005 | 35 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.070 |
Why?
|
| Mass Screening | 1 | 2022 | 5255 | 0.070 |
Why?
|
| Shiga Toxin | 1 | 2005 | 34 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2018 | 224 | 0.070 |
Why?
|
| Ivermectin | 1 | 2005 | 42 | 0.070 |
Why?
|
| Advisory Committees | 2 | 2022 | 775 | 0.070 |
Why?
|
| Th17 Cells | 3 | 2022 | 766 | 0.070 |
Why?
|
| Gastritis | 1 | 2007 | 196 | 0.070 |
Why?
|
| Prevalence | 4 | 2018 | 15226 | 0.070 |
Why?
|
| Epitopes | 2 | 2022 | 2571 | 0.070 |
Why?
|
| Aphasia, Broca | 1 | 2005 | 50 | 0.070 |
Why?
|
| Tanzania | 1 | 2010 | 1346 | 0.070 |
Why?
|
| Indonesia | 1 | 2005 | 119 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 1999 | 404 | 0.060 |
Why?
|
| Bacillus | 1 | 2005 | 77 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2018 | 6171 | 0.060 |
Why?
|
| Rectum | 2 | 2009 | 904 | 0.060 |
Why?
|
| Skin | 1 | 2019 | 4364 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2400 | 0.060 |
Why?
|
| Sex Factors | 2 | 2017 | 10397 | 0.060 |
Why?
|
| Empyema, Pleural | 1 | 2005 | 62 | 0.060 |
Why?
|
| Gene Library | 2 | 2005 | 1074 | 0.060 |
Why?
|
| Mycobacterium smegmatis | 1 | 2005 | 122 | 0.060 |
Why?
|
| Retinal Detachment | 1 | 2009 | 411 | 0.060 |
Why?
|
| Eye | 1 | 2009 | 729 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 1992 | 1416 | 0.060 |
Why?
|
| Retinopathy of Prematurity | 1 | 2009 | 421 | 0.060 |
Why?
|
| Aortography | 1 | 2005 | 437 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12026 | 0.060 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.060 |
Why?
|
| Decision Making | 1 | 2018 | 3887 | 0.060 |
Why?
|
| Zinc | 3 | 2017 | 684 | 0.060 |
Why?
|
| Retinal Vein Occlusion | 1 | 2005 | 137 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20129 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
| Echinococcus | 1 | 2003 | 16 | 0.060 |
Why?
|
| Boston | 2 | 2020 | 9313 | 0.060 |
Why?
|
| Retinal Vessels | 1 | 2009 | 772 | 0.060 |
Why?
|
| Epidemiologic Methods | 2 | 2018 | 1364 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2011 | 9146 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1607 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2018 | 23403 | 0.060 |
Why?
|
| Liver | 1 | 2019 | 7474 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3047 | 0.060 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2002 | 12 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2023 | 53288 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3309 | 0.050 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2002 | 24 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2012 | 1563 | 0.050 |
Why?
|
| Trypanosomiasis, African | 1 | 2002 | 28 | 0.050 |
Why?
|
| Antibodies | 2 | 2021 | 2460 | 0.050 |
Why?
|
| Antacids | 1 | 2022 | 99 | 0.050 |
Why?
|
| Knowledge | 1 | 2024 | 181 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4386 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1099 | 0.050 |
Why?
|
| HIV-1 | 1 | 2020 | 6939 | 0.050 |
Why?
|
| Radiography | 2 | 2011 | 7023 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3527 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2023 | 160 | 0.050 |
Why?
|
| Central Nervous System Infections | 1 | 2002 | 56 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2278 | 0.050 |
Why?
|
| DNA, Bacterial | 3 | 2014 | 1465 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
| Pneumothorax | 1 | 2005 | 379 | 0.050 |
Why?
|
| Th1 Cells | 3 | 2012 | 1057 | 0.050 |
Why?
|
| Azithromycin | 1 | 2023 | 196 | 0.050 |
Why?
|
| Poverty | 1 | 2013 | 2660 | 0.050 |
Why?
|
| Th2 Cells | 3 | 2012 | 1061 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2440 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2022 | 172 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 13989 | 0.050 |
Why?
|
| Environmental Exposure | 2 | 2013 | 4234 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2005 | 554 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10481 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 401 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 394 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17446 | 0.050 |
Why?
|
| Microbial Interactions | 1 | 2021 | 76 | 0.050 |
Why?
|
| Biopsy | 3 | 2019 | 6756 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2022 | 1940 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 1572 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8642 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2021 | 349 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4328 | 0.050 |
Why?
|
| Intubation | 1 | 2020 | 141 | 0.050 |
Why?
|
| Health Surveys | 1 | 2010 | 4037 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2023 | 862 | 0.050 |
Why?
|
| Africa | 2 | 2018 | 673 | 0.050 |
Why?
|
| Health Personnel | 1 | 2014 | 3218 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2013 | 7729 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2017 | 2559 | 0.050 |
Why?
|
| Abdominal Pain | 2 | 2019 | 1063 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
| Sodium Acetate | 1 | 2019 | 7 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2000 | 168 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2020 | 365 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2020 | 265 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 252 | 0.040 |
Why?
|
| Colony Count, Microbial | 2 | 2012 | 331 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2009 | 2250 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 440 | 0.040 |
Why?
|
| Lipid A | 1 | 2019 | 67 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 426 | 0.040 |
Why?
|
| Public Health | 1 | 2012 | 2603 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
| Inflammasomes | 2 | 2015 | 495 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 208 | 0.040 |
Why?
|
| Awareness | 1 | 2023 | 640 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 562 | 0.040 |
Why?
|
| Eosinophils | 1 | 2004 | 955 | 0.040 |
Why?
|
| Health Status | 1 | 2012 | 4034 | 0.040 |
Why?
|
| Brain | 2 | 2021 | 26385 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 2001 | 208 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 571 | 0.040 |
Why?
|
| Endotoxins | 1 | 2021 | 527 | 0.040 |
Why?
|
| Models, Biological | 2 | 2019 | 9583 | 0.040 |
Why?
|
| Endometriosis | 1 | 2006 | 839 | 0.040 |
Why?
|
| Culture Media | 1 | 2020 | 908 | 0.040 |
Why?
|
| Biotechnology | 1 | 2020 | 281 | 0.040 |
Why?
|
| Disease Notification | 1 | 2018 | 97 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 682 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2021 | 1682 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2015 | 5319 | 0.040 |
Why?
|
| Sudan | 1 | 2018 | 83 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 276 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2001 | 724 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 21827 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 1333 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 1009 | 0.040 |
Why?
|
| Aorta | 1 | 2005 | 2061 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1237 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 12072 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 3760 | 0.040 |
Why?
|
| Massachusetts | 2 | 2020 | 8663 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4803 | 0.040 |
Why?
|
| Family | 3 | 2015 | 3147 | 0.040 |
Why?
|
| Viremia | 1 | 2020 | 736 | 0.040 |
Why?
|
| Dyspnea | 1 | 2005 | 1303 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2021 | 9849 | 0.040 |
Why?
|
| Americas | 1 | 2017 | 111 | 0.040 |
Why?
|
| Consciousness Disorders | 1 | 2021 | 418 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2020 | 959 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2017 | 145 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 2011 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2018 | 526 | 0.040 |
Why?
|
| Biostatistics | 1 | 2018 | 162 | 0.040 |
Why?
|
| Glutamine | 1 | 2000 | 578 | 0.040 |
Why?
|
| Specialization | 1 | 2021 | 777 | 0.040 |
Why?
|
| Hybridomas | 1 | 2017 | 452 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15165 | 0.040 |
Why?
|
| Dependovirus | 1 | 2021 | 706 | 0.030 |
Why?
|
| Water | 1 | 2022 | 1395 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 79 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 2017 | 881 | 0.030 |
Why?
|
| Oxides | 1 | 2017 | 405 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2000 | 1079 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 18111 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 176 | 0.030 |
Why?
|
| Mutation | 3 | 2022 | 29786 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2171 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2015 | 132 | 0.030 |
Why?
|
| Age Distribution | 2 | 2014 | 2902 | 0.030 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Bacteria | 1 | 2006 | 2114 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 523 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1053 | 0.030 |
Why?
|
| Vitamin A | 2 | 2008 | 615 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6196 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1999 | 1266 | 0.030 |
Why?
|
| Spirometry | 1 | 2017 | 864 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1654 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10388 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 79 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 2005 | 1139 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 13815 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 592 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 713 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10252 | 0.030 |
Why?
|
| Malabsorption Syndromes | 1 | 2014 | 135 | 0.030 |
Why?
|
| Temperature | 1 | 2020 | 2206 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 777 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 153 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 375 | 0.030 |
Why?
|
| Africa, Western | 1 | 2013 | 154 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1354 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3528 | 0.030 |
Why?
|
| Yellow fever virus | 1 | 2013 | 22 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2019 | 506 | 0.030 |
Why?
|
| Parasites | 1 | 1996 | 163 | 0.030 |
Why?
|
| Computational Biology | 1 | 2005 | 3521 | 0.030 |
Why?
|
| Genotype | 3 | 2015 | 12951 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.030 |
Why?
|
| Uganda | 1 | 2017 | 1243 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 1743 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 551 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1609 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2005 | 5985 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2013 | 290 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1623 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 2557 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2020 | 2902 | 0.030 |
Why?
|
| Altruism | 1 | 2014 | 204 | 0.030 |
Why?
|
| Genomics | 2 | 2018 | 5720 | 0.030 |
Why?
|
| Friends | 1 | 2013 | 154 | 0.030 |
Why?
|
| Logistic Models | 3 | 2012 | 13408 | 0.030 |
Why?
|
| Cryptosporidium parvum | 1 | 2012 | 43 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 1751 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1916 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1405 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 504 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2022 | 5456 | 0.020 |
Why?
|
| Birth Order | 1 | 1992 | 95 | 0.020 |
Why?
|
| Pedigree | 2 | 2009 | 4644 | 0.020 |
Why?
|
| Occupations | 1 | 2013 | 517 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 565 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 99 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 39050 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1200 | 0.020 |
Why?
|
| Cattle | 1 | 2017 | 3922 | 0.020 |
Why?
|
| Kinetics | 1 | 2019 | 6473 | 0.020 |
Why?
|
| Public Health Informatics | 1 | 2011 | 110 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5974 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 981 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3200 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1992 | 11727 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1072 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2011 | 237 | 0.020 |
Why?
|
| Diet | 1 | 2008 | 7939 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2007 | 1241 | 0.020 |
Why?
|
| Morbidity | 1 | 1996 | 1769 | 0.020 |
Why?
|
| Nigeria | 1 | 2013 | 733 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 120 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77449 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2009 | 76 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 300 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8324 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 553 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9386 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 214 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7301 | 0.020 |
Why?
|
| Neutrophils | 1 | 2022 | 3719 | 0.020 |
Why?
|
| Iron | 1 | 2017 | 1774 | 0.020 |
Why?
|
| Recurrence | 2 | 2014 | 8340 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 1988 | 74 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3778 | 0.020 |
Why?
|
| Maternal Age | 1 | 1992 | 802 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2018 | 1859 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 81 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 63114 | 0.020 |
Why?
|
| Serum | 1 | 2009 | 214 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 914 | 0.020 |
Why?
|
| Gaucher Disease | 1 | 1988 | 112 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 1988 | 119 | 0.020 |
Why?
|
| Bacteriolysis | 1 | 2007 | 51 | 0.020 |
Why?
|
| Internet | 1 | 2000 | 3064 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2005 | 4266 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2007 | 240 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2256 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 892 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2007 | 190 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1275 | 0.020 |
Why?
|
| Gene Expression | 1 | 2000 | 7799 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6150 | 0.020 |
Why?
|
| Societies | 1 | 2006 | 104 | 0.020 |
Why?
|
| Serum Bactericidal Test | 1 | 2005 | 3 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 522 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 3 | 2014 | 7279 | 0.020 |
Why?
|
| Sleep | 1 | 2021 | 4623 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 156 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2126 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2006 | 207 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
| Military Personnel | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Chest Pain | 1 | 1992 | 1114 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2007 | 356 | 0.020 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 251 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2499 | 0.020 |
Why?
|
| Mucins | 1 | 2007 | 564 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5097 | 0.020 |
Why?
|
| Peru | 1 | 2007 | 881 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 12797 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2715 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1997 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2266 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 184 | 0.010 |
Why?
|
| Birth Weight | 1 | 1992 | 2069 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 2003 | 117 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4931 | 0.010 |
Why?
|
| Gestational Age | 1 | 1992 | 3493 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13102 | 0.010 |
Why?
|
| Compartment Syndromes | 1 | 2005 | 153 | 0.010 |
Why?
|
| Suramin | 1 | 2002 | 34 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1827 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2297 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 2005 | 546 | 0.010 |
Why?
|
| Trypanocidal Agents | 1 | 2002 | 38 | 0.010 |
Why?
|
| Foot Dermatoses | 1 | 2002 | 44 | 0.010 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4149 | 0.010 |
Why?
|
| Mannose-Binding Lectin | 1 | 2003 | 150 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Multigene Family | 1 | 2005 | 1102 | 0.010 |
Why?
|
| Anthrax | 1 | 2002 | 88 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3588 | 0.010 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2002 | 66 | 0.010 |
Why?
|
| Virulence Factors | 1 | 2005 | 509 | 0.010 |
Why?
|
| Erythema | 1 | 2002 | 257 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
| Drug Design | 1 | 2006 | 1076 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4479 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2002 | 281 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2726 | 0.010 |
Why?
|
| Metronidazole | 1 | 2001 | 217 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 594 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2002 | 534 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5102 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 6442 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 1071 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 2002 | 481 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 1643 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6933 | 0.010 |
Why?
|
| Anemia | 1 | 2007 | 1506 | 0.010 |
Why?
|
| Vancomycin | 1 | 2001 | 501 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2002 | 639 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4740 | 0.010 |
Why?
|
| Vero Cells | 1 | 1997 | 485 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2006 | 2684 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9687 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
| Colon | 1 | 2001 | 1772 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15519 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8664 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1988 | 803 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9648 | 0.000 |
Why?
|